Elsevier Launches New Stem Cell Book Series

Each volume focuses on stem cells in an individual organ and how to use them alongside relevant methods and protocols


CAMBRIDGE, MA--(Marketwired - May 23, 2017) - Elsevier, the information analytics company specializing in science and health, today announced a new book series, Advances in Stem Cells and their Niches. This series addresses stem cells during development, homeostasis, and disease or injury of the respective organs, presenting new developments in the field, including new data on disease and clinical applications. The first volume in the series, Hematopoietic Stem Cell Niche, is available now. Elsevier also announced the publication of six additional genetics, genomics and stem cell medicine books.

Each volume in the Advances in Stem Cells and their Niches series focuses on an individual organ, looking at the stem cells in that organ itself (if they exist), their niches, and how to use them alongside relevant methods and protocols. Edited by Dominique Bonnet, the new series includes video content illustrating such areas as protocols, transplantation techniques, and work with mice.

Learn more about stroma cell niche regulation during HSC development in this sample chapter from Volume 1.

Dr. Dominique Bonnet is a senior group leader at the Francis Crick Institute in London. Her group is investigating the molecular programs that regulate both human normal and leukemic stem cells. She is also interested in deciphering the role played by the microenvironment or niche in this regulation and finding new potential targets to eradicate the leukemic stem cell pool. Dr. Bonnet is also a professor at the University College of London and a senior lecturer at the Institute of Child Health.

The seven new genetics, genomics and stem cell titles are:

In order to meet content needs in genetics, genomics and stem cell medicine, Elsevier uses proprietary tools to identify the gaps in coverage of the topics. Editorial teams strategically fill those gaps with content written by key influencers in the field, giving students, faculty and researchers the content they need to answer challenging questions and improve outcomes. These new books, which will educate the next generation of geneticists and genomicists, and provide critical foundational content for information professionals, are key examples of how Elsevier is enabling science to drive innovation.

---

Note for Editors
Only credentialed media can request eBook review copies by email, sciencereviewcopies@elsevier.com

About Elsevier
Elsevier is a global information analytics company that helps institutions and professionals progress science, advance healthcare and improve performance for the benefit of humanity. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, more than 35,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX Group, a global provider of information and analytics for professionals and business customers across industries. www.elsevier.com

Image Available: http://www.marketwire.com/library/MwGo/2017/5/22/11G139391/Images/Hematopoietic_Stem_Cell_Niche_cover-732dbce99c1a87fe94a2431a08c71538.jpg

Contact Information:

Media Contact
Pam Foote
Publicity Contact, Science & Technology Books, Elsevier
footep@reedelsevier.com
+1-978-837-8182

Elsevier, books, information analytics, stem cell, genetic, genomic, homeostasis, disease